With Novartis' new treatment for spinal muscular atrophy (SMA) projected to exceed $4 million per patient, Dr. Mark Trolice of Fertility CARE: The IVF Center advocates for genetic tests and IVF that can prevent the disease at 1/25 the cost. ...
SAN FRANCISCO , Feb. 5, 2019 /PRNewswire/ -- Global & U.S. Gene Therapy Market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe. Gene Therapy is ...
Rare Disease patients will receive whole genome sequencing and personalized reports for $299 (€259). NEW YORK , Feb. 4, 2019 /PRNewswire/ -- Global genomic company Dante Labs announced today the launch of an exclusive Whole Genome ...
Pioneers in Direct-to-Consumer DNA Test Kits Work with F.B.I. to Catch Killers HOUSTON , Jan. 31, 2019 /PRNewswire/ -- In 2000, when Bennett Greenspan , President and Founder of Gene-by-Gene Ltd. and FamilyTreeDNA, launched FamilyTreeDNA ...
Copay penalties and incentives to be used to engage members in specialty drug management. PARK CITY, Utah , Jan. 31, 2019 /PRNewswire-PRWeb/ -- Based on the success of its initial specialty drug care management program, Allied National, ...
- $500,000 funding to improve Duchenne muscular dystrophy diagnosis and screening in 2019 - SOUTH PLAINFIELD, N.J. , Jan. 31, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today launched PRIORITY, an annual funding program for ...
NEW YORK , Jan. 31, 2019 /PRNewswire/ -- Genomic Prediction , developer of the world's first and only polygenic disease screening tests for improving IVF health outcomes, announced today that it has raised $4.5 million through the sale ...
RARITAN, N.J. , Jan. 31, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a worldwide collaboration and license agreement with MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage gene ...
Initial clinical study to evaluate ACTUS-101 over 52 weeks that could improve quality of life for those who are affected with rare genetic disorder - Pompe Disease. RESEARCH TRIANGLE PARK, N.C. , Jan. 29, 2019 /PRNewswire-PRWeb/ -- Actus ...
A study released today in STEM CELLS Translational Medicine provides a deeper and clearer understanding of how patients suffering vision loss in both eyes due to limbal stem cell deficiency (LSCD) might benefit from a stem cell transplant using ...
Children born through frozen embryo transfer have metabolic profiles similar to those born through fresh embryo transfer, according to a study published on June 6th in the open-access journal PLOS Medicine by Linlin Cui, Zi-Jiang Chen from Shandong ...
Alterations in the SCN2A gene influence the age of seizure onset and the severity of neurological impairments in affected children, aiding in the identification of suitable candidates for precision medicines and gene therapies in clinical trials , as ...
Assistant Prof. Ibrahim, Bitar, Department of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic presents a research review elucidating CRISPR's molecular biology and its potential in addressing antimicrobial ...
Genetic predisposition towards greater muscle strength is associated with a longer lifespan and reduced vulnerability to common diseases, based on analysis of health and genome...
Stem cell therapy emerges as a viable and safe choice for individuals grappling with challenging traumatic spinal cord injuries , said experts ( ). Stem Cell Therapy’s Safety and Promising Benefits "This study documents the safety and ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers